THAT — Thalia Therapeutics Cashflow Statement
0.000.00%
Last trade - 00:00- £11.10m
- £9.59m
- £0.01m
Annual cashflow statement for Thalia Therapeutics, fiscal year end - December 31st, GBP millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | C2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | Interim Report | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -1.54 | -1.03 | -1.28 | -1.12 | -1.21 |
| Non-Cash Items | -0.282 | -0.14 | -0.141 | -0.033 | 0.056 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.054 | 0.341 | 0.212 | 0.181 | -0.009 |
| Change in Accounts Receivable | |||||
| Change in Accounts Payable | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -1.77 | -0.828 | -1.21 | -0.972 | -1.16 |
| Other Investing Cash Flow Items | — | — | 0.001 | 0 | — |
| Sale of Business | |||||
| Cash from Investing Activities | — | — | 0.001 | 0 | — |
| Financing Cash Flow Items | 0.001 | -0.09 | -0.038 | -0.06 | -0.136 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Cash from Financing Activities | 0.001 | 0.964 | 0.312 | 0.57 | 1.61 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -1.77 | 0.136 | -0.892 | -0.401 | 0.453 |